The following are major and regular CU DRC events:
Please join us at our events!
Hybrid insulin peptides (HIPs) form in pancreatic beta cells and are targeted by autoreactive T cells in Type 1 Diabetes. The Delong group identified cathepsin D (CatD) as a key enzyme responsible for the formation of a group of HIPs contributing to disease progression. His group investigates the role of these HIPs in mediating disease progression and whether CatD-mediated HIP formation is a potential target to block the autoimmune destruction of beta cells. Join us to learn more about Professor Delong's research findings on this critical aspect of Type 1 Diabetes pathogenesis.
When: March 10, 2025, 12 pm to 1 pm
Where: Barbara Davis Center (M20), Level 2, Main Conference Room 2104
Speaker:
Thomas Delong
Associate Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
Click here for speaker’s bio and publications.